A biotech angel investment fund founded in 2016 and headquartered in Taiwan has a fund size of $50M and an average ticket size range from $250K to $1M. The fund mainly focuses on early-stage biotechnology and medical device companies and is looking to invest in seed to pre-A round.
The firm is looking for new investment opportunities across a wide spectrum of life science sectors. The current pipeline includes biotechnology platforms, medical devices, therapeutics and service platforms.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Leave a Reply